CTHIn ForceLegislation
National Health (Botulinum Toxin Program) Special Arrangement 2025
Schedule 1Botulinum toxin pharmaceutical benefits
Start here
Get a plain-English read of Schedule 1
Turn the raw legal text into a practical explanation grounded in National Health (Botulinum Toxin Program) Special Arrangement 2025.
## Schedule 1—Botulinum toxin pharmaceutical benefits
Note: See the definition of botulinum toxin pharmaceutical benefit in section 6.
| Listed Drug | Form | Manner of Administration | Brand |
| ----------------------------------------------------------- | ----------------------------------------------- | ------------------------ | ------- |
| Botulinum toxin type A purified neurotoxin complex | Lyophilised powder for injection 100 units | Injection | Botox |
| Clostridium botulinum type A toxin ‑ haemagglutinin complex | Lyophilised powder for I.M. injection 300 units | Injection | Dysport |
| Clostridium botulinum type A toxin ‑ haemagglutinin complex | Lyophilised powder for I.M. injection 500 units | Injection | Dysport |
| IncobotulinumtoxinA | Lyophilised powder for injection 100 units | Injection | Xeomin |
> Note: Each listed drug mentioned in the table has been declared by the Minister under subsection 85(2) of the Act. The form, manner of administration and brand mentioned in the table have been determined by the Minister under subsections 85(3), (5) and (6) of the Act respectively.